To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Myotonic dystrophy type 1 (DM1)
Cell culture and mouse studies suggest inhibiting miR-23b
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury